Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Stephan

Showing results (111-120 of 146) with videos related to

Pageof 15
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|October 20, 2020
Effectiveness and Safety of Interferon-Free Direct-Acting Antiviral Hepatitis C Virus Therapy in HIV/Hepatitis C Virus Coinfected Individuals: Results From a Pan-European StudySarah Amele, Lars Peters, Alison Rodger, et al.
AIDS Research and Therapy|November 16, 2019
Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study)Guido Schäfer, Christian Hoffmann, Keikawus Arasteh, et al.
JACC. Cardiovascular Imaging|April 18, 2021
Myocardial Fibrosis and Inflammation by CMR Predict Cardiovascular Outcome in People Living With HIVPhilipp de Leuw, Christophe T Arendt, Annette E Haberl, et al.
AIDS (London, England)|August 23, 2018
Aging and the evolution of comorbidities among HIV-positive individuals in a European cohortAnnegret Pelchen-Matthews, Lene Ryom, Álvaro H Borges, et al.
International Journal of Antimicrobial Agents|July 13, 2026
Outcomes for persons with triple-class resistant HIV and a history of virologic failureSuzanne M Ingle, Fabrice Bonnet, Linda Wittkop, et al.
AIDS (London, England)|May 25, 2021
Prevalence and outcomes of pregnancies in women with HIV over a 20-year periodJustyna D Kowalska, Annegret Pelchen-Matthews, Lene Ryom, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 19, 2023
Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 TrialAbiu Sempere, Lambert Assoumou, Ana González-Cordón, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2022
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized TrialLaura Waters, Lambert Assoumou, Ana González-Cordón, et al.
AIDS Research and Therapy|August 6, 2022
Observational cohort study of rilpivirine (RPV) utilization in EuropeAlessandro Cozzi-Lepri, Lars Peters, Annegret Pelchen-Matthews, et al.
HIV Research & Clinical Practice|November 15, 2021
Hypersensitivity reactions, hepatotoxicity, and other discontinuations in persons receiving integrase strand transfer inhibitors: results from the EuroSIDA studyAnnegret Pelchen-Matthews, Jakob Friis Larsen, Leah Shepherd, et al.
Pageof 15

Showing results (111-120 of 146) with videos related to

Sort By:
Pageof 15
Journal of Acquired Immune Deficiency Syndromes (1999)|October 20, 2020
Effectiveness and Safety of Interferon-Free Direct-Acting Antiviral Hepatitis C Virus Therapy in HIV/Hepatitis C Virus Coinfected Individuals: Results From a Pan-European StudySarah Amele, Lars Peters, Alison Rodger, et al.
AIDS Research and Therapy|November 16, 2019
Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study)Guido Schäfer, Christian Hoffmann, Keikawus Arasteh, et al.
JACC. Cardiovascular Imaging|April 18, 2021
Myocardial Fibrosis and Inflammation by CMR Predict Cardiovascular Outcome in People Living With HIVPhilipp de Leuw, Christophe T Arendt, Annette E Haberl, et al.
AIDS (London, England)|August 23, 2018
Aging and the evolution of comorbidities among HIV-positive individuals in a European cohortAnnegret Pelchen-Matthews, Lene Ryom, Álvaro H Borges, et al.
International Journal of Antimicrobial Agents|July 13, 2026
Outcomes for persons with triple-class resistant HIV and a history of virologic failureSuzanne M Ingle, Fabrice Bonnet, Linda Wittkop, et al.
AIDS (London, England)|May 25, 2021
Prevalence and outcomes of pregnancies in women with HIV over a 20-year periodJustyna D Kowalska, Annegret Pelchen-Matthews, Lene Ryom, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 19, 2023
Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 TrialAbiu Sempere, Lambert Assoumou, Ana González-Cordón, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2022
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized TrialLaura Waters, Lambert Assoumou, Ana González-Cordón, et al.
AIDS Research and Therapy|August 6, 2022
Observational cohort study of rilpivirine (RPV) utilization in EuropeAlessandro Cozzi-Lepri, Lars Peters, Annegret Pelchen-Matthews, et al.
HIV Research & Clinical Practice|November 15, 2021
Hypersensitivity reactions, hepatotoxicity, and other discontinuations in persons receiving integrase strand transfer inhibitors: results from the EuroSIDA studyAnnegret Pelchen-Matthews, Jakob Friis Larsen, Leah Shepherd, et al.
Pageof 15